EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Principles of Immunotherapeutic Drug Discovery for Severe Infections Using Extreme Phenotypes

Clark D Russell, Annette C Westgeest

Critical Care Clinics · 2026-10 · 42 (4) · 763-775

DOI: 10.1016/j.ccc.2026.05.004 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Critical Care Clinics, 2026-10. Verfasst von Clark D Russell und 1 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK. Electronic address: clark.russell@ed…. Hauptthemen laut MEDLINE: Drug Discovery, Immunotherapy, COVID-19, COVID-19 Drug Treatment. Die Arbeit nennt 67 Literaturangaben. Gefördert von: Chief Scientist Office.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Therapeutically modifying host responses in severe infection is an unmet need in critical care, either to augment pathogen clearance or limit immunopathology. Drug discovery in this space is impeded by the complexity of immune responses during infection. Identifying and studying extreme infection phenotypes is an emerging approach to negotiate this problem: by amplifying biological signal over noise, this can expedite the discovery of host determinants of severe disease or protection. Examples discussed in this article include critical Covid-19, HIV elite controllers, inborn errors of interferon gamma immunity, hypervirulent pathogen variants, and sepsis hyper-inflammatory and immunoparalysis subphenotypes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug DiscoveryImmunotherapyCOVID-19COVID-19 Drug TreatmentHumansPhenotypeHost-Directed TherapyHIV InfectionsSARS-CoV-2Critical Illness

Stichwörter der Autor:innen

Critical illnessExtreme phenotypeHIV elite controllerHost-directed therapyHyper-virulent pathogen variantsInterferon gammaSubphenotypes

Autor:innen und Institutionen

  • Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK. Electronic address: clark.russell@ed.ac.uk.
  • Leiden University Center for Infectious Diseases (LUCID), Leiden University Medical Center, Albinusdreef 2, Leiden, The Netherlands.

Förderung

  • Chief Scientist Office

Zitieren

APA

Russell, C. D., & Westgeest, A. C. (2026). Principles of Immunotherapeutic Drug Discovery for Severe Infections Using Extreme Phenotypes. Critical Care Clinics, 42(4), 763-775. https://doi.org/10.1016/j.ccc.2026.05.004

Vancouver

Russell CD, Westgeest AC. Principles of Immunotherapeutic Drug Discovery for Severe Infections Using Extreme Phenotypes. Critical Care Clinics. 2026;42(4):763-775. doi:10.1016/j.ccc.2026.05.004

BibTeX
@article{Russell2026,
  author = {Russell, Clark D and Westgeest, Annette C},
  title = {Principles of Immunotherapeutic Drug Discovery for Severe Infections Using Extreme Phenotypes},
  journal = {Critical Care Clinics},
  year = {2026},
  volume = {42},
  number = {4},
  pages = {763--775},
  doi = {10.1016/j.ccc.2026.05.004}
}
Kostenlos starten →